Anbio Biotechnology banner
A

Anbio Biotechnology
NASDAQ:NNNN

Watchlist Manager
Anbio Biotechnology
NASDAQ:NNNN
Watchlist
Price: 24.9 USD 7.05% Market Closed
Market Cap: $3.6B

Anbio Biotechnology
Investor Relations

Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Michael Lau M.B.A., Ph.D.
Chief Executive Officer
No Bio Available
Ms. Suki Song CPA
Chief Financial Officer
No Bio Available
Mr. Chris Tian
Chief Business Officer
No Bio Available

Contacts

Address
HESSEN
Frankfurt
Wilhelm Gutbrod Str 21b
Contacts
+4916096247281